89 related articles for article (PubMed ID: 1359494)
21. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1.
Pietrzkowski Z; Mulholland G; Gomella L; Jameson BA; Wernicke D; Baserga R
Cancer Res; 1993 Mar; 53(5):1102-6. PubMed ID: 8439954
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of alternatively spliced mRNA forms of the insulin-like growth factor 1 receptor in human neuroendocrine tumors.
Vitale L; Lenzi L; Huntsman SA; Canaider S; Frabetti F; Casadei R; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
Oncol Rep; 2006 May; 15(5):1249-56. PubMed ID: 16596194
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor (IGF) 2 stimulates steroidogenesis and mitosis of bovine granulosa cells through the IGF1 receptor: role of follicle-stimulating hormone and IGF2 receptor.
Spicer LJ; Aad PY
Biol Reprod; 2007 Jul; 77(1):18-27. PubMed ID: 17360960
[TBL] [Abstract][Full Text] [Related]
25. Expression of human proliferation-associated nucleolar antigen p120.
Jhiang SM; Yaneva M; Busch H
Cell Growth Differ; 1990 Jul; 1(7):319-24. PubMed ID: 2278884
[TBL] [Abstract][Full Text] [Related]
26. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
[TBL] [Abstract][Full Text] [Related]
27. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells.
Kanatani Y; Kasukabe T; Okabe-Kado J; Hayashi S; Yamamoto-Yamaguchi Y; Motoyoshi K; Nagata N; Honma Y
Cell Growth Differ; 1996 Feb; 7(2):187-96. PubMed ID: 8822202
[TBL] [Abstract][Full Text] [Related]
29. [Inhibition of lens epithelial cell cycle and PCNA mRNA expression by an antisense oligonucleotides complementary to the messenger RNA of proliferating cell nuclear antigen].
Weng JN; Zhang HR
Zhonghua Yan Ke Za Zhi; 2003 Feb; 39(2):98-101. PubMed ID: 12783689
[TBL] [Abstract][Full Text] [Related]
30. Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.
Taipale J; Matikainen S; Hurme M; Keski-Oja J
Cell Growth Differ; 1994 Dec; 5(12):1309-19. PubMed ID: 7696179
[TBL] [Abstract][Full Text] [Related]
31. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines.
Li BD; Budnick RM; Russo CA; Anderson GR; Stewart CC
J Surg Res; 1995 Oct; 59(4):485-92. PubMed ID: 7564322
[TBL] [Abstract][Full Text] [Related]
32. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
[TBL] [Abstract][Full Text] [Related]
33. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
[TBL] [Abstract][Full Text] [Related]
34. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G
Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression.
Venturelli D; Travali S; Calabretta B
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5963-7. PubMed ID: 1696013
[TBL] [Abstract][Full Text] [Related]
36. [Proto-oncogene, proliferating cell nuclear antigen, perforin and growth factor gene expression in peripheral blood mononuclear cells from patients with IgA nephropathy].
Nakamura T; Ebihara I; Koide H
Nihon Rinsho; 1992 Dec; 50(12):3056-63. PubMed ID: 1362782
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
Citro G; Perrotti D; Cucco C; D'Agnano I; Sacchi A; Zupi G; Calabretta B
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7031-5. PubMed ID: 1495997
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of cell cycle progression by antisense oligodeoxynucleotides.
Baserga R; Reiss K; Alder H; Pietrzkowski Z; Surmacz E
Ann N Y Acad Sci; 1992 Oct; 660():64-9. PubMed ID: 1340157
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
Citro G; Szczylik C; Ginobbi P; Zupi G; Calabretta B
Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of gastric cancer cell proliferation by antisense oligonucleotides targeting the messenger RNA encoding proliferating cell nuclear antigen.
Sakakura C; Hagiwara A; Tsujimoto H; Ozaki K; Sakakibara T; Oyama T; Ogaki M; Takahashi T
Br J Cancer; 1994 Dec; 70(6):1060-6. PubMed ID: 7981055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
